News

14/11/2016

Magnasense Technologies' representatives will be available November 14-17, 2016, at the Medica trade show in Düsseldorf, Germany. 

Magnasense Technologies will present its novel sensitive point of care (PoC) assay system utilising paramagnetically labelled antibodies (Magnetic ImmunoAssay, MIA) and the Magnia® reader.

The Magnia® CRP assay, combining speed, convenience and high perfomance will be presented.


Come and meet us at Hall 1 stand D18 and learn more about the Magnia® system or to discuss how Magnasense's technology can be applied to your product range.

Call +358-40-7266683 to book a meeting.

We look forward to hearing from you.
07/04/2014

 

Magnasense Technologies will be presenting its novel, sensitive Point-of-Care (PoC) assay system utilising paramagnetically labelled antibodies (Magnetic ImmunoAssay, MIA) at the 10th International Conference on the Scientific and Clinical Applications of Magnetic Carriers, Dresden Germany. June 10-14 2014.

Magnasense Technologies will be presenting a poster on the development of assays utilising paramagnetically labelled nanoparticles plus their application via the Magnia® reader and the Magnia CRP assay.

Come and meet us to learn more about Magnasense's novel MIA technology and system.

Call +358-40-7266683 or Email info@magnasense.com to book a meeting.

We look forward to hearing from you.

01/04/2014

We are pleased to announce that Magnasense Technologies’ quality management system (QMS) has been certified by DNVGL (a global leader in quality certification www.DNLGV.com) as being compliant with ISO 13485.

ISO 13485 is the internationally recognised standard for quality management systems in the medical device industry. It specifies requirements for a quality management system where an organisation needs to demonstrate its ability to provide medical devices, and that related services consistently meet customer and applicable regulatory requirements.

Achievement of ISO 13485 accreditation is another step in Magnasense Technologies’ continuous commitment to high product quality and excellent customer service.

For more information, please contact info@magnasense.com and a representative from Magnasense Technologies will rapidly get back to you.

18/09/2013

Magnasense Technologies is pleased to announce the launch of the first ImmunoMagnetoMetricAssay for the important clinical biomarker – C-Reactive protein (CRP).


CRP is an important biomarker of inflammation utilised in two areas: Slightly elevated levels are a valuable parameter when evaluating cardiovascular risk while strongly elevated levels are an important aid in diagnosing bacterial infections. Developing an assay that can cover both these diagnostic ranges is difficult, but Magnasense Technologies have achieved this by utilising antibodies labelled with paramagnetic nanoparticles and the high sensitivity and wide dynamic range of the Magnia® reader.

 

The Magnasense Technologies Magnia® CRP assay is highly sensitive and quantitative but requires only a 10µL whole blood sample and 10 minutes incubation time.

 

All reagents and disposables are included in the kit and, together with the portable and convenient Magnia® reader, it enables this valuable clinical test to be performed in doctors’ offices and health centres for maximum patient benefit and convenience.

 

If you would like to know more about the Magnia® CRP assay, please contact: info@magnasense.com or telephone 00358 40 7266683.